National Diabetes Strategy National Diabetes Strategy An Integrated Approach to Quality Improvement
Conflict of interest declaration Monica Skarulis Young, M.D. Director National Obesity Treatment Center Deputy Director Qatar Metabolic Institute No conflicts
Diabetes Mellitus: A Complex Group of Chronic Progressive Diseases of Glucose Metabolism Hyperglycemia Type 1 ~10% Children, young adults Autoimmune, β-cell destruction Complications Type 2 ~90% Adults (recent adolescents) Obesity, insulin resistance Gestational Genetic causes (rare) Secondary Other diseases Medications Blindness (RETINOPATHY) Renal Failure (NEPHROPATHY) Pain (NEUROPATHY) Poor wound healing Amputation Heart attacks Cerebrovascular Disease MICRO Vasculature MACRO
Advanced Diabetes Complications PATIENT VISITS(N) PERCENT WITH DIABETES ACUTE CORONARY SYNDROME HEART FAILURE 6,767 65% STROKE + TIA 1924 54% DIALYSIS 76,063 61% AMPUTATIONS 146 47% Source: HMC Cerner Data Analysis - 2016
Comprehensive Coordinated Care to Prevent Diabetes Complications Diabetes prevention! Focus on healthy lifestyle Diabetes screening for early detection Diabetes treatment to achieve safe glycemic targets Treatment of hypertension and hyperlipidemia Detection and treatment of retinopathy Detection of neuropathy and preventive foot care Provide support to maintain motivation and monitor mental health
National Diabetes Strategy Preventing Diabetes Together 2016-2022
National Diabetes Strategy An Integrated Approach to Quality Improvement Dr. Al-Anoud Al Thani, MoPH National Diabetes Strategy Updates Dr. Samya Ahmad Al Abdulla, PHCC Diabetes Screening and Risk Factors: Safe SMART Screening (SSS) Dr. Mahmoud Al Zirie, HMC National Diabetes Guidelines and care pathways Dr. Khalid A Noor A.M. Saifeldeen, HMC National Diabetes Strategy – Online Education Package Moderator: Dr. Monica Skarulis Young, Director of the National Obesity Treatment Center